Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    17321312 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
Condition: Coronary Artery Disease
Intervention: Device: Qvanteq bioactive coronary stent
2 Completed Six-month Coverage and Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography
Condition: Acute Myocardial Infarction
Interventions: Device: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA);   Device: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca);   Device: Coronary stent implantation;   Device: Bare Metal Coronary Stent
3 Recruiting Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up
Condition: Coronary Artery Disease
Interventions: Device: Coroflex® ISAR Drug-eluting stent;   Device: Ultimaster® Drug-eluting stent
4 Recruiting Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study
Condition: Coronary Heart Disease
Intervention: Device: Angiolite stent
5 Active, not recruiting RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
Condition: In-Stent Restenosis
Interventions: Device: Coronary angioplasty using the paclitaxel-eluting balloon;   Device: Coronary angioplasty using the everolimus-eluting stent
6 Unknown  RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
Condition: In-stent Restenosis
Interventions: Device: Coronary angioplasty using the paclitaxel-eluting balloon;   Device: Coronary angioplasty using the Everolimus-eluting stent
7 Active, not recruiting BES, EES, and ZES-R in Real World Practice
Condition: Coronary Artery Disease
Interventions: Device: Biolimus-eluting stent;   Device: Everolimus-eluting stent;   Device: Zotarolimus-eluting stent
8 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent

Study has passed its completion date and status has not been verified in more than two years.